WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2022)
Top diagnostic & research stocks in 2022 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
SHC
SOTERA HEALTH CO
NASDAQ
Diagnostics & Research
$2.00B$7.06-1.26%$400.18M16.05x3.47
CODX
CO-DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$111.82M$3.31-0.90%$34.38M3.56x0.11
QDEL
QUIDELORTHO CORP
NASDAQ
Diagnostics & Research
$4.85B$72.400.67%$1.42B3.04x0.79
MEDP
MEDPACE HOLDINGS INC
NASDAQ
Diagnostics & Research
$5.22B$168.260.51%$277.34M28.00x3.64
NEOG
NEOGEN CORP
NASDAQ
Diagnostics & Research
$1.43B$13.28-3.42%$68.88M39.06x0.11
SYNH
SYNEOS HEALTH INC
NASDAQ
Diagnostics & Research
$5.14B$50.06-2.42%$684.86M18.54x1.47
FLGT
FULGENT GENETICS INC
NASDAQ
Diagnostics & Research
$1.16B$38.450.31%$550.41M2.94x0.12
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Diagnostics & Research
$5.14B$74.70-3.82%$113.61M162.39x0.79
DMTK
DERMTECH INC
NASDAQ
Diagnostics & Research
$115.65M$3.85-3.75%-$102.08M-1.08x0.21
BWAY
BRAINSWAY LTD
NASDAQ
Diagnostics & Research
$62.04M$3.771.34%-$5.04M-8.57x0.34
DRIO
DARIOHEALTH CORP
NASDAQ
Diagnostics & Research
$126.16M$5.496.60%-$73.62M-1.46x0.38
PHG
KONINKLIJKE PHILIPS NV
NYSE
Diagnostics & Research
$13.72B$15.77-1.99%$5.37B3.78x1.14
DXCM
DEXCOM INC
NASDAQ
Diagnostics & Research
$37.38B$95.214.53%$388.50M185.96x1.31
TMO
THERMO FISHER SCIENTIFIC INC
NYSE
Diagnostics & Research
$211.80B$540.59-1.04%$11.99B28.53x1.14
CSTL
CASTLE BIOSCIENCES INC
NASDAQ
Diagnostics & Research
$724.22M$27.54-5.56%-$47.71M-15.74x0.09
SERA
SERA PROGNOSTICS INC
NASDAQ
Diagnostics & Research
$54.56M$1.761.73%-$44.98M-1.50x0.07
DGX
QUEST DIAGNOSTICS INC
NYSE
Diagnostics & Research
$14.70B$126.06-1.33%$2.51B10.25x1.07
ICLR
ICON PLC
NASDAQ
Diagnostics & Research
$15.76B$193.37-1.95%$1.06B72.42x1.09
SENS
SENSEONICS HOLDINGS INC
NYSEMKT
Diagnostics & Research
$614.39M$1.32-1.49%$337.08M1.83x10.00
LHDX
LUCIRA HEALTH INC
NASDAQ
Diagnostics & Research
$48.13M$1.200.84%-$36.00M-1.12x0.56
CDNA
CAREDX INC
NASDAQ
Diagnostics & Research
$962.25M$18.00-1.15%-$57.62M-13.64x0.22
A
AGILENT TECHNOLOGIES INC
NYSE
Diagnostics & Research
$39.13B$132.18-0.35%$1.91B29.90x1.06
MTD
METTLER TOLEDO INTERNATIONAL INC
NYSE
Diagnostics & Research
$27.08B$1,203.180.06%$1.16B33.51x458.44
QGEN
QIAGEN NV
NYSE
Diagnostics & Research
$10.02B$44.000.94%$889.78M19.56x0.88
MOTS
MOTUS GI HOLDINGS INC
NASDAQ
Diagnostics & Research
$7.79M$2.6038.30%-$17.54M-0.25x4.06
TWST
TWIST BIOSCIENCE CORP
NASDAQ
Diagnostics & Research
$2.20B$39.111.56%-$200.43M-9.90x0.19
IDXX
IDEXX LABORATORIES INC
NASDAQ
Diagnostics & Research
$28.81B$346.02-1.17%$962.18M44.08x4.71
BNGO
BIONANO GENOMICS INC
NASDAQ
Diagnostics & Research
$626.70M$2.16-1.37%-$103.16M-5.84x0.13
NRC
NATIONAL RESEARCH CORP
NASDAQ
Diagnostics & Research
$979.54M$39.551.38%$54.42M27.66x0.99
GENE
GENETIC TECHNOLOGIES LTD
NASDAQ
Diagnostics & Research
$22.81M$1.242.07%-$5.03M-3.65x0.27
WAT
WATERS CORP
NYSE
Diagnostics & Research
$17.22B$287.55-1.13%$992.24M24.92x6.75
MXCT
MAXCYTE INC
NASDAQ
Diagnostics & Research
$741.57M$7.290.00%-$17.78M-36.45x0.13
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
NYSE
Diagnostics & Research
$10.72B$210.81-2.14%$863.13M24.04x1.83
OLK
OLINK HOLDING AB (PUBL)
NASDAQ
Diagnostics & Research
$1.68B$14.13-0.63%-$13.36M-56.52x0.15
BNR
BURNING ROCK BIOTECH LTD
NASDAQ
Diagnostics & Research
$258.57M$2.46-5.38%N/A-1.84x0.30
AWH
ASPIRA WOMEN's HEALTH INC
NASDAQ
Diagnostics & Research
$40.43M$0.36-11.76%-$35.86M-1.13x0.70
PSNL
PERSONALIS INC
NASDAQ
Diagnostics & Research
$157.50M$3.43-1.01%-$86.67M-1.64x0.35
PRPO
PRECIPIO INC
NASDAQ
Diagnostics & Research
$19.67M$0.872.73%-$9.26M-1.88x0.26
PKI
PERKINELMER INC
NYSE
Diagnostics & Research
$16.36B$129.61-1.32%$1.49B24.05x0.98
CHEK
CHECK-CAP LTD
NASDAQ
Diagnostics & Research
$33.76M$0.29-0.68%-$18.69M-1.32x0.10
BMRA
BIOMERICA INC
NASDAQ
Diagnostics & Research
$54.24M$4.05-1.94%-$3.91M-11.25x0.37
MYGN
MYRIAD GENETICS INC
NASDAQ
Diagnostics & Research
$1.65B$20.41-1.97%$20.20M-88.74x0.28
RNLX
RENALYTIX PLC
NASDAQ
Diagnostics & Research
$44.47M$1.23-8.89%-$54.27M-0.89x0.51
LH
LABORATORY CORP OF AMERICA HOLDINGS
NYSE
Diagnostics & Research
$19.01B$210.27-2.21%$3.63B9.98x0.96
BVS
BIOVENTUS INC
NASDAQ
Diagnostics & Research
$544.48M$7.03-0.71%$20.95M-21.30x1.54
NTRA
NATERA INC
NASDAQ
Diagnostics & Research
$4.56B$47.030.84%-$540.73M-7.75x1.40
STIM
NEURONETICS INC
NASDAQ
Diagnostics & Research
$84.31M$3.12-6.31%-$31.85M-2.24x0.80
CNTG
CENTOGENE NV
NASDAQ
Diagnostics & Research
$31.14M$1.152.68%-$25.55M-0.49x2.32
BIOC
BIOCEPT INC
NASDAQ
Diagnostics & Research
$14.81M$0.88-2.02%-$5.05M-1.62x0.67
XGN
EXAGEN INC
NASDAQ
Diagnostics & Research
$45.53M$2.80-1.41%-$33.47M-1.27x0.68
OPGN
OPGEN INC
NASDAQ
Diagnostics & Research
$12.95M$0.27-4.29%-$18.58M-0.34x0.78
VIVO
MERIDIAN BIOSCIENCE INC
NASDAQ
Diagnostics & Research
$1.40B$31.950.06%$75.48M32.27x0.28
ONVO
ORGANOVO HOLDINGS INC
NASDAQ
Diagnostics & Research
$18.47M$2.120.00%-$11.96M-1.53x0.11
DHR
DANAHER CORP
NYSE
Diagnostics & Research
$202.27B$278.05-1.50%$10.12B32.22x0.76
ME
23ANDME HOLDING CO
NASDAQ
Diagnostics & Research
$1.46B$3.240.00%-$238.09M-5.31x0.24
MYNZ
MAINZ BIOMED NV
NASDAQ
Diagnostics & Research
$91.39M$6.31-3.74%-$23.76M-315.50x0.16
ISPC
ISPECIMEN INC
NASDAQ
Diagnostics & Research
$14.74M$1.66-1.78%-$8.37M-2.34x0.20
GTH
GENETRON HOLDINGS LTD
NASDAQ
Diagnostics & Research
$76.65M$0.831.22%N/A-0.92x0.28
CELC
CELCUITY INC
NASDAQ
Diagnostics & Research
$154.64M$10.353.19%-$28.68M-5.07x0.36
CEMI
CHEMBIO DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$13.21M$0.445.05%-$30.38M-0.34x1.82
IQV
IQVIA HOLDINGS INC
NYSE
Diagnostics & Research
$34.98B$187.54-2.57%$2.86B30.74x3.56
BDSX
BIODESIX INC
NASDAQ
Diagnostics & Research
$59.97M$1.50-2.60%-$46.49M-0.83x8.81
ANIX
ANIXA BIOSCIENCES INC
NASDAQ
Diagnostics & Research
$150.55M$4.91-1.60%-$14.09M-10.45x0.05
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
NASDAQ
Diagnostics & Research
$1.54B$6.874.89%-$269.54M-7.31x1.75
EXAS
EXACT SCIENCES CORP
NASDAQ
Diagnostics & Research
$6.43B$36.320.72%-$505.99M-8.57x1.01
SLNO
SOLENO THERAPEUTICS INC
NASDAQ
Diagnostics & Research
$35.04M$1.730.58%-$21.17M-1.07x0.82
GH
GUARDANT HEALTH INC
NASDAQ
Diagnostics & Research
$6.11B$59.77-0.02%-$492.35M-11.05x4.81
HSKA
HESKA CORP
NASDAQ
Diagnostics & Research
$841.06M$77.743.71%-$6.10M-45.20x0.41
ILMN
ILLUMINA INC
NASDAQ
Diagnostics & Research
$33.46B$212.72-2.65%$387.00M-2,659.00x0.48
NEO
NEOGENOMICS INC
NASDAQ
Diagnostics & Research
$1.14B$9.05-1.09%-$78.97M-7.54x0.72
SQL
SEQLL INC
NASDAQ
Diagnostics & Research
$8.56M$0.72-2.17%-$3.71M-2.06x0.58
NDRA
ENDRA LIFE SCIENCES INC
NASDAQ
Diagnostics & Research
$20.85M$0.336.80%-$11.99M-1.22x0.15
AXDX
ACCELERATE DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$134.57M$1.65-3.51%-$52.12M-1.76x-1.95
RDNT
RADNET INC
NASDAQ
Diagnostics & Research
$1.13B$19.74-2.81%$259.53M47.00x5.73
SRDX
SURMODICS INC
NASDAQ
Diagnostics & Research
$442.98M$31.63-2.56%-$5.73M-34.38x0.40
LMDX
LUMIRADX LTD
NASDAQ
Diagnostics & Research
$262.88M$1.033.31%$74.72M20.60x8.14
NOTV
INOTIV INC
NASDAQ
Diagnostics & Research
$496.77M$19.41-7.22%-$30.04MN/A0.90
VNRX
VOLITIONRX LTD
NYSEMKT
Diagnostics & Research
$95.69M$1.677.05%-$29.15M-2.98x4.54
AKU
AKUMIN INC
NASDAQ
Diagnostics & Research
$171.87M$1.92-1.03%$61.29M-1.73x35.05
HTGM
HTG MOLECULAR DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$6.31M$0.571.24%-$19.93M-0.22x2.99
LAB
STANDARD BIOTOOLS INC
NASDAQ
Diagnostics & Research
$99.11M$1.26-3.82%-$159.48M-0.60x-4.47
OPK
OPKO HEALTH INC
NASDAQ
Diagnostics & Research
$1.43B$1.85-3.14%-$89.84M-6.17x0.38
PMD
PSYCHEMEDICS CORP
NASDAQ
Diagnostics & Research
$35.61M$6.33-4.95%$2.17M-30.14x0.71
NVTA
INVITAE CORP
NYSE
Diagnostics & Research
$630.51M$2.68-2.90%-$3.00B-0.20x4.94
TTOO
T2 BIOSYSTEMS INC
NASDAQ
Diagnostics & Research
$37.37M$0.117.07%-$51.50M-0.30x-2.06
QTNT
QUOTIENT LTD
NASDAQ
Diagnostics & Research
$21.73M$0.160.00%-$91.81M-0.12x-2.16
ENZ
ENZO BIOCHEM INC
NYSE
Diagnostics & Research
$110.11M$2.26-2.59%-$3.95M-16.14x0.67
PRE
PRENETICS GLOBAL LTD
NASDAQ
Diagnostics & Research
$401.75M$3.62-0.82%N/A-0.23x0.27
TRIB
TRINITY BIOTECH PLC
NASDAQ
Diagnostics & Research
$25.29M$1.21-0.82%N/AN/A-17.88
MDXH
MDXHEALTH SA
NASDAQ
Diagnostics & Research
$103.72M$6.65-3.98%N/AN/A0.97
BIAF
BIOAFFINITY TECHNOLOGIES INC
NASDAQ
Diagnostics & Research
N/A$2.905.07%N/AN/A-0.82
VRAX
VIRAX BIOLABS GROUP LTD
NASDAQ
Diagnostics & Research
$27.18M$2.39-5.53%-$1.69M-3.57x-1.28

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Oct 2022?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Sotera Health Co (NASDAQ:SHC)


Sotera Health Co (NASDAQ:SHC) is the top diagnostic & research stock with a Zen Score of 61, which is 28 points higher than the diagnostic & research industry average of 33. It passed 20 out of 33 due diligence checks and has strong fundamentals. Sotera Health Co has seen its stock lose -72.67% over the past year, underperforming other diagnostic & research stocks by -42 percentage points.

Sotera Health Co has an average 1 year price target of $15.86, an upside of 124.6% from Sotera Health Co's current stock price of $7.06.

Sotera Health Co stock has a consensus Hold recommendation according to Wall Street analysts. Of the 8 analysts covering Sotera Health Co, 0% have issued a Strong Buy rating, 12.5% have issued a Buy, 75% have issued a hold, while 0% have issued a Sell rating, and 12.5% have issued a Strong Sell.

2. Co Diagnostics (NASDAQ:CODX)


Co Diagnostics (NASDAQ:CODX) is the second best diagnostic & research stock with a Zen Score of 57, which is 24 points higher than the diagnostic & research industry average of 33. It passed 18 out of 33 due diligence checks and has strong fundamentals. Co Diagnostics has seen its stock lose -61.01% over the past year, underperforming other diagnostic & research stocks by -30 percentage points.

Co Diagnostics has an average 1 year price target of $7.00, an upside of 111.48% from Co Diagnostics's current stock price of $3.31.

Co Diagnostics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Co Diagnostics, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Quidelortho (NASDAQ:QDEL)


Quidelortho (NASDAQ:QDEL) is the third best diagnostic & research stock with a Zen Score of 56, which is 23 points higher than the diagnostic & research industry average of 33. It passed 18 out of 33 due diligence checks and has strong fundamentals. Quidelortho has seen its stock lose -46.47% over the past year, underperforming other diagnostic & research stocks by -16 percentage points.

Quidelortho has an average 1 year price target of $104.00, an upside of 43.65% from Quidelortho's current stock price of $72.40.

Quidelortho stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Quidelortho, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 9 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Koninklijke Philips Nv (NYSE:PHG)


Koninklijke Philips Nv (NYSE:PHG) has an annual dividend yield of 6.11%, which is 4 percentage points higher than the diagnostic & research industry average of 1.71%. Koninklijke Philips Nv's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Koninklijke Philips Nv's dividend has not shown consistent growth over the last 10 years.

Koninklijke Philips Nv's dividend payout ratio of 24.8% indicates that its high dividend yield is sustainable for the long-term.

2. Psychemedics (NASDAQ:PMD)


Psychemedics (NASDAQ:PMD) has an annual dividend yield of 3%, which is 1 percentage points higher than the diagnostic & research industry average of 1.71%. Psychemedics's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Psychemedics's dividend has not shown consistent growth over the last 10 years.

Psychemedics's dividend payout ratio of -57.1% indicates that its dividend yield might not be sustainable for the long-term.

3. National Research (NASDAQ:NRC)


National Research (NASDAQ:NRC) has an annual dividend yield of 2.12%, which is the same as the diagnostic & research industry average of 1.71%. National Research's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. National Research's dividend has not shown consistent growth over the last 10 years.

National Research's dividend payout ratio of 50.3% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.84% in the last day, and up 6.44% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Sotera Health Co (NASDAQ:SHC)


Sotera Health Co (NASDAQ:SHC) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Sotera Health Co has a valuation score of 86, which is 50 points higher than the diagnostic & research industry average of 36. It passed 6 out of 7 valuation due diligence checks.

Sotera Health Co's stock has dropped -72.67% in the past year. It has underperformed other stocks in the diagnostic & research industry by -42 percentage points.

2. Syneos Health (NASDAQ:SYNH)


Syneos Health (NASDAQ:SYNH) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Syneos Health has a valuation score of 86, which is 50 points higher than the diagnostic & research industry average of 36. It passed 6 out of 7 valuation due diligence checks.

Syneos Health's stock has dropped -41.86% in the past year. It has underperformed other stocks in the diagnostic & research industry by -11 percentage points.

3. Quidelortho (NASDAQ:QDEL)


Quidelortho (NASDAQ:QDEL) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Quidelortho has a valuation score of 86, which is 50 points higher than the diagnostic & research industry average of 36. It passed 6 out of 7 valuation due diligence checks.

Quidelortho's stock has dropped -46.47% in the past year. It has underperformed other stocks in the diagnostic & research industry by -16 percentage points.

Are diagnostic & research stocks a good buy now?

45.24% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 39.05% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is -76.99x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.